Moloney Securities Asset Management, LLC Cyto Dyn Inc. Transaction History
Moloney Securities Asset Management, LLC
- $666 Million
- Q2 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 28,025 shares of CYDY stock, worth $3,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,025
Previous 28,025
-0.0%
Holding current value
$3,643
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CYDY
# of Institutions
12Shares Held
442KCall Options Held
0Put Options Held
0-
Eagle Bay Advisors LLC New York, NY162KShares$21,0740.01% of portfolio
-
Diversified Trust CO45.8KShares$5,9520.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$5,8500.0% of portfolio
-
Mai Capital Management42.5KShares$5,5220.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$5,3880.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $106M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...